IRS2 and prostate cancer: Furthermore, the IRS2/PI3K/AKT axis, which involves the insulin receptor substrate 2 (IRS2) signaling pathway, the phosphoinositide 3‐kinase (PI3K), and protein kinase B (AKT), plays a crucial role in prostate cancer development.14, 15